• Something wrong with this record ?

Modulation of aryl hydrocarbon receptor activity by halogenated indoles

A. Vrzalová, R. Vrzal, P. Nádvorník, M. Šebela, Z. Dvořák

. 2024 ; 114 (-) : 117964. [pub] 20241019

Language English Country England, Great Britain

Document type Journal Article

The aryl hydrocarbon receptor (AhR) is a cytosolic ligand-activated transcription factor integral to various physiological and pathological processes. Among its diverse ligands, indole-based compounds have garnered attention due to their significant biological activity and potential therapeutic applications. This study explores the activation of AhR by structurally diverse halogenated indoles. We evaluated the transcriptional activity of AhR and cell viability in the human LS174T-AhR-luc reporter cell line. Among the tested compounds, 4-FI, 7-FI, 6-BrI, 7-BrI, 6-Cl-2-ox, 5-Br-2-ox, and 6-Br-2-ox activated AhR in a concentration-dependent manner, displaying high efficacy and potency. Molecular docking analysis revealed moderate binding affinities of these compounds to the PAS-B domain of AhR, corroborated by competitive radioligand binding assays. Functional assays showed that halogenated indoles induce the formation of AhR-ARNT heterodimer and enhance the binding of the AhR to the CYP1A1 promoter. Additionally, 4-FI and 7-FI exhibited anti-inflammatory properties in Caco-2 cell models, highlighting their potential for therapeutic applications. This study underscores the significance of the type and position of halogen moiety in indole scaffold, suggesting their potential as candidates for developing therapeutics drugs to treat conditions such as inflammatory bowel disease via AhR activation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003452
003      
CZ-PrNML
005      
20250206104342.0
007      
ta
008      
250121e20241019enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bmc.2024.117964 $2 doi
035    __
$a (PubMed)39454560
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vrzalová, Aneta $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic. Electronic address: aneta.vrzalova@upol.cz
245    10
$a Modulation of aryl hydrocarbon receptor activity by halogenated indoles / $c A. Vrzalová, R. Vrzal, P. Nádvorník, M. Šebela, Z. Dvořák
520    9_
$a The aryl hydrocarbon receptor (AhR) is a cytosolic ligand-activated transcription factor integral to various physiological and pathological processes. Among its diverse ligands, indole-based compounds have garnered attention due to their significant biological activity and potential therapeutic applications. This study explores the activation of AhR by structurally diverse halogenated indoles. We evaluated the transcriptional activity of AhR and cell viability in the human LS174T-AhR-luc reporter cell line. Among the tested compounds, 4-FI, 7-FI, 6-BrI, 7-BrI, 6-Cl-2-ox, 5-Br-2-ox, and 6-Br-2-ox activated AhR in a concentration-dependent manner, displaying high efficacy and potency. Molecular docking analysis revealed moderate binding affinities of these compounds to the PAS-B domain of AhR, corroborated by competitive radioligand binding assays. Functional assays showed that halogenated indoles induce the formation of AhR-ARNT heterodimer and enhance the binding of the AhR to the CYP1A1 promoter. Additionally, 4-FI and 7-FI exhibited anti-inflammatory properties in Caco-2 cell models, highlighting their potential for therapeutic applications. This study underscores the significance of the type and position of halogen moiety in indole scaffold, suggesting their potential as candidates for developing therapeutics drugs to treat conditions such as inflammatory bowel disease via AhR activation.
650    12
$a receptory aromatických uhlovodíků $x metabolismus $x chemie $7 D018336
650    _2
$a lidé $7 D006801
650    12
$a indoly $x chemie $x farmakologie $7 D007211
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    12
$a simulace molekulového dockingu $7 D062105
650    _2
$a molekulární struktura $7 D015394
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a halogenace $7 D054879
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
650    _2
$a transkripční faktory bHLH $7 D051792
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic
700    1_
$a Nádvorník, Petr $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic
700    1_
$a Šebela, Marek $u Department of Biochemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic
700    1_
$a Dvořák, Zdeněk $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Olomouc, Czech Republic
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $x 1464-3391 $g Roč. 114 (20241019), s. 117964
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39454560 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104337 $b ABA008
999    __
$a ok $b bmc $g 2263305 $s 1239459
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 114 $c - $d 117964 $e 20241019 $i 1464-3391 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...